Several pathways, such as cadherin, Alzheimer's disease, and angiogenesis signaling, highlighted to be associated with WBP2 in this proteogenomic study have yet been explored. This evidence concerns the gene CDH17 and early-onset autosomal dominant Alzheimer disease.